Skip to main content
Aldawaa Medical Services Co. logo

Aldawaa Medical Services Co. — Investor Relations & Filings

Ticker · 4163 ISIN · SA15H14I11H6 Saudi Exchange Wholesale and retail trade
Open in API
Filings indexed 59 across all filing types
Latest filing 2026-05-12 Proxy Solicitation & In…
Country SA Saudi Arabia
Listing Saudi Exchange 4163

About Aldawaa Medical Services Co.

http://www.al-dawaa.com

Aldawaa Medical Services Co. is a prominent healthcare retail organization specializing in the distribution and sale of pharmaceutical products, medical equipment, and consumer health goods. The company operates an extensive network of pharmacies, providing a comprehensive range of prescription medications, over-the-counter drugs, beauty products, and wellness supplies. Leveraging a sophisticated logistics infrastructure and automated distribution centers, the firm ensures efficient supply chain management and product availability. Aldawaa integrates digital health solutions through its e-commerce platform and mobile application, facilitating remote consultations and home delivery services. Its business model emphasizes patient-centric care, quality assurance, and the adoption of advanced technological systems to enhance the retail pharmacy experience.

Recent filings

Filing Released Lang Actions
Aldawaa Medical Services Co. Board invites its shareholders to attend the Extraordinary General Assembly Meeting the (First Meeting)
Proxy Solicitation & Information Statement Classification · 90% confidence The document is an official invitation to shareholders for an Extraordinary General Assembly meeting, including details on meeting logistics, agenda items, proxy forms, and voting instructions. This matches the definition of ‘Proxy Solicitation & Information Statement’ (PSI), which covers materials sent to shareholders to provide information about a meeting and request their votes.
2026-05-12 English
Announcement of the inability to publish preliminary financial results for the first quarter of the period ending March 31, 2026 (three months).
Regulatory Filings Classification · 85% confidence The document is a public announcement regarding the company’s inability to publish its preliminary Q1 financial results on time, outlining reasons, timetables, and trading suspension details. It does not contain any financial statements or actual results, nor is it the report itself. It is a general regulatory disclosure required by the exchange. Therefore, it falls under Regulatory Filings (RNS).
2026-05-12 English
Aldawaa Medical Services Co. announces the board of director’s decision to distribute cash dividends for The fourth Quarter of the year ended 31/12/2025.
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Aldawaa Medical Services Co. regarding the board of directors' decision to distribute cash dividends for the fourth quarter of the year ended 31/12/2025. It includes details such as the total amount distributed, dividend per share, eligibility date, and distribution date. The document is short (3004 characters) and focuses solely on dividend distribution details without containing any financial statements or comprehensive financial analysis. It is not a full report but an announcement of dividend payment. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2026-05-04 English
Aldawaa Medical Services Co. announces its Annual Financial results for the period ending on 2025-12-31
Earnings Release Classification · 95% confidence The document is an announcement of Aldawaa Medical Services Co.'s annual financial results for the period ending 2025-12-31. It includes key financial figures such as sales, gross profit, operational profit, net profit, and shareholders' equity, along with explanations for changes in revenue and net profit. The document also mentions the auditor's opinion as unmodified but does not contain the full annual report or detailed financial statements. The length is 4349 characters, which is relatively short and typical for an earnings release or financial results announcement rather than a full annual report. The document is titled as an announcement of annual financial results, which aligns with an Earnings Release (ER) rather than a full Annual Report (10-K). Therefore, the appropriate classification is Earnings Release (ER).
2026-05-04 English
Correction announcement from the Al-Dawaa Medical Services Company for medical services regarding the supplementary announcement published on April 28, 2026
Regulatory Filings Classification · 80% confidence The document is a short issuer announcement correcting a previously published supplementary announcement on the Saudi Exchange. It does not contain or attach any financial report itself, nor does it announce dividend, board changes, financing updates, or other specific report types. It is a miscellaneous regulatory disclosure, best fitting the fallback category for general regulatory announcements.
2026-04-28 English
Supplementary announcement from Al-Dawaa Medical Services Company regarding the previous announcement published on 31/3/2026 AD, concerning the inability to publish the annual financial results for th
Report Publication Announcement Classification · 96% confidence The document is a supplementary announcement notifying stakeholders of a delay in publishing the annual financial results for the period ending December 31, 2025. It does not contain the actual report but provides an update on its publication timing and audit status. This aligns with ‘Report Publication Announcement (RPA)’ – announcements regarding the timing or publication of company reports.
2026-04-28 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.